{{ctm}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 448706716
| image = Gardasil vaccine and box new.jpg
<!-- Vacine data -->
| type = vaccine
| target = 人类乳突病毒（16、18、6、11型）
| vaccine_type = protein subunit
<!-- Clinical data -->
| tradename = Gardasil
| Drugs.com = {{drugs.com|monograph|human-papillomavirus-vaccine}}
| MedlinePlus = a607016
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = Rx-only
| routes_of_administration = 肌肉注射
<!-- Identifiers -->
| ATC_prefix = J07
| ATC_suffix = BM01
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number = 910046-32-1
| CAS_number_Ref = {{cascite|correct|CAS}}
<!-- Chemical data -->
}}

'''加衛苗''',（亦作'''Gardasil'''、'''Gardisil'''、'''Silgard'''、'''recombinant human papillomavirus vaccine [types 6, 11, 16, 18]'''），<ref name="silgard">{{cite web | url = http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm | title = Silgard European Public Assessment Report | publisher = [[歐洲藥品管理局|歐洲藥品管理局]] | date = September 25, 2009 | accessdate = 2009-12-05 | deadurl = yes | archiveurl = https://web.archive.org/web/20091226091139/http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm | archivedate = 2009-12-26 }}</ref><ref>{{cite web|last=Waknine|first=Yael|url=http://www.medscape.com/viewarticle/545374|title=International Approvals: Singulair and Gardasil/Silgard|date=October 2, 2006|work=Medscape Today|accessdate=2008-12-18|archive-date=2013-05-20|archive-url=https://web.archive.org/web/20130520232942/http://www.medscape.com/viewarticle/545374|dead-url=no}}</ref>是[[人類乳突病毒疫苗|人類乳突病毒疫苗]]的一种，用于预防特定[[毒株|毒株]]的[[人类乳突病毒|人类乳突病毒]]（HPV），<ref>{{cite news | url = http://www.reuters.com/article/rbssPharmaceuticals%20-%20Generic%20&%20Specialty/idUSN2052127820090820 | title = UPDATE 2-U.S. health officials back safety of Merck vaccine | work = Reuters | date = August 20, 2009 | accessdate = 2009-11-12 | first = Lisa | last = Richwine | archive-date = 2009-08-27 | archive-url = https://web.archive.org/web/20090827011806/http://www.reuters.com/article/rbssPharmaceuticals%20-%20Generic%20%26%20Specialty/idUSN2052127820090820 | dead-url = no }}</ref>特别是6，11，16和18型。<ref name=pmid_17380109>{{Cite journal | last1 = Markowitz | first1 = L. E. | last2 = Dunne | first2 = E. F. | last3 = Saraiya | first3 = M. | last4 = Lawson | first4 = H. W. | last5 = Chesson | first5 = H. | last6 = Unger | first6 = E. R. | author7 = Centers for Disease Control Prevention (CDC) | author8 = Advisory Committee on Immunization Practices (ACIP) | title = Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) | journal = MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control | volume = 56 | issue = RR-2 | pages = 1–24 | year = 2007 | pmid = 17380109 | url = http://www.cdc.gov/mmwr/pdf/rr/rr5602.pdf | access-date = 2016-03-06 | archive-date = 2015-09-24 | archive-url = https://web.archive.org/web/20150924044909/http://www.cdc.gov/mmwr/pdf/rr/rr5602.pdf | dead-url = no }}</ref><ref name=pmid_20508594>{{Cite journal | author1 = Centers for Disease Control and Prevention (CDC) | title = FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP) | journal = MMWR. Morbidity and mortality weekly report | volume = 59 | issue = 20 | pages = 630–632 | year = 2010 | pmid = 20508594 | url = http://www.cdc.gov/mmwr/pdf/wk/mm5920.pdf | access-date = 2016-03-06 | archive-date = 2015-09-24 | archive-url = https://web.archive.org/web/20150924044945/http://www.cdc.gov/mmwr/pdf/wk/mm5920.pdf | dead-url = no }}</ref>约70%的[[子宫颈癌|子宫颈癌]]<ref name="pmid16670757">{{cite journal | author = Lowy DR, Schiller JT | title = Prophylactic human papillomavirus vaccines | journal = J. Clin. Invest. | volume = 116 | issue = 5 | pages = 1167–73 | date = May 2006 | pmid = 16670757 | doi = 10.1172/JCI28607 | url = http://www.jci.org/articles/view/JCI28607 | accessdate = 2009-11-12 | pmc = 1451224 | archive-date = 2008-12-29 | archive-url = https://web.archive.org/web/20081229010905/http://www.jci.org/articles/view/JCI28607 | dead-url = yes }}</ref><ref name="Muñoz2004">{{cite journal| author = Muñoz N, Bosch FX, Castellsagué X| title = Against which human papillomavirus types shall we vaccinate and screen? The international perspective| journal = Int. J. Cancer| volume = 111| issue = 2| pages = 278–85|date=August 2004| doi = 10.1002/ijc.20244| pmid = 15197783}}</ref>，以及大多数的[[肛门癌|肛门癌]]<ref name="Bloomberg">{{cite news | url=http://www.bloomberg.com/apps/news?pid=20601202&sid=aajzweDaXZh0&refer=healthcare | author=Cortez, Michelle Fay | author2=Pettypiece, Shannon | title=Merck Cancer Shot Cuts Genital Warts, Lesions in Men (Update2) | work=Bloomberg News | date=13 November 2008 | accessdate=2009-11-12 }}{{dead link|date=2017年11月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>、[[外陰癌|外陰癌]]、[[阴道癌|阴道癌]]<ref name="VulvarCA">{{cite press release | url = http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116945.htm | title = FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers | accessdate = 2009-11-11 | date = 2008-09-12 | publisher = [[美國食品藥品監督管理局|美國食品藥品監督管理局]] (FDA) | archive-date = 2010-03-06 | archive-url = https://web.archive.org/web/20100306073734/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116945.htm | dead-url = no }}</ref>和[[阴茎癌|阴茎癌]]由16和18型HPV病毒感染造成。约90%的[[尖锐湿疣|尖锐湿疣]]病例由6型和11型的HPV病毒感染引起。尽管加卫苗不能清除体内已经存在的病毒，仍然推荐HPV阳性患者接种，因为疫苗可以使患者免受其他种类毒株的感染。<ref>{{cite web|title=The Ethics of Vaccination | url = http://www.credoreference.com.wc-ezproxy.westminster.edu/enrty/suppbioeth/the_ethics_of_vaccination|publisher=Springer Publishing Company|accessdate=2013-09-29}}</ref>加卫苗所预防的毒株都是通过[[性傳染病|性行为传播]]的。加卫苗在2006年6月8日由[[美國食品藥品監督管理局|美国食药监局]]认可。至2008年，[[美国|美国]]41个州也相继认可了该疫苗。<ref>{{cite web|title=The Ethics of vaccination|url=http://www.credoreference.com.wc-ezproxy.westminster.edu/entry/suppbopeth/the_ethics_of_vaccination|publisher=Springer Publishing Company|accessdate=2013-10-03}}</ref>除美国外，还有120个国家认可加卫苗。<ref>{{cite journal|last=Haupt|first=Richard|author2=Sings, Heather|title=The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil|journal=Journal of Adolescent Health|date=November 2011|volume=49|issue=5|pages=467–475|doi=10.1016/jodohealth.2011.07.003|pmid=22018560|accessdate=2013-09-27}}</ref>美国食药监局建议青春期前及无性行为经验的人群接种该疫苗。<ref name=pmid_17380109/><ref name="gardasilPI">{{cite web| url=http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf| title=Gardasil full prescribing information| publisher=[[Merck_&_Co.|Merck & Co.]]| accessdate=2009-11-11| archive-date=2012-03-18| archive-url=https://www.webcitation.org/66GSUD1h0?url=http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf| dead-url=no}}</ref><ref name="FDAgardasil">{{cite web | url=http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm179549.htm | title=Gardasil Vaccine Safety | date=August 20, 2009 | work=Vaccine Safety & Availability | publisher=[[美國食品藥品監督管理局|美國食品藥品監督管理局]] (FDA) | accessdate=2009-11-11 | archive-date=2009-11-15 | archive-url=https://web.archive.org/web/20091115095513/http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm179549.htm | dead-url=no }}</ref>

2014年12月，美国食药监局又认可了一支基于加卫苗开发的九价HPV疫苗，加卫-9<ref group="注">亦作：Gardasil 9</ref>。这支疫苗新增了5种HPV毒株的表面蛋白<ref group="注">这五种毒株分别是HPV-31、HPV-33、HPV-45、HPV-52和HPV-58，20%的子宫颈癌由它们引起。</ref><ref name= Gardasil9>{{cite web|url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm|type=press release|title=FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV|date=10 December 2014|accessdate=28 February 2015|archive-date=2015-01-10|archive-url=https://web.archive.org/web/20150110233107/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm|dead-url=no}}</ref>。

== 注解 ==
{{Reflist|colwidth=30em|group="注"}}

== 参考 ==
{{Reflist|colwidth=30em}}

== 外部链接 ==
* {{Official website|http://www.gardasil.com/}}
* [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000732/WC500051550.pdf Silgard EPAR summary for the public]{{Wayback|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000732/WC500051550.pdf |date=20160303214541 }}
* {{Cite journal| last1 = Shi | first1 = L| last2 = Sings | first2 = HL| last3 = Bryan | first3 = JT| last4 = Wang | first4 = B| last5 = Wang | first5 = Y| last6 = Mach | first6 = H| last7 = Kosinski | first7 = M| last8 = Washabaugh | first8 = MW| last9 = Sitrin | first9 = R| last10 = Barr | first10 = E| title = Gardasil: prophylactic human papillomavirus vaccine development – from bench top to bed-side| url = https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2007-02_81_2/page/259 | journal = Clinical Pharmacology & Therapeutics| volume = 81| issue = 2| pages = 259–64|date=February 2007| doi = 10.1038/sj.clpt.6100055| issn = 0009-9236}}
* {{Cite journal | url = http://www.rochester.edu/pr/Review/V68N3/feature1.html | title = A Cancer Vaccine is Born | last = Ireland | first = Corydon | work = Rochester Review | publisher = [[University_of_Rochester|University of Rochester]] | volume = 68 | issue = 3 | year = 2006 | journal =  | access-date = 2016-03-06 | archive-date = 2016-03-04 | archive-url = https://web.archive.org/web/20160304191207/http://www.rochester.edu/pr/Review/V68N3/feature1.html | dead-url = yes }}
* {{Cite news | last = Harris | first = Gardiner | url = http://www.nytimes.com/2006/06/30/health/30vaccine.html | title = Panel Unanimously Recommends Cervical Cancer Vaccine for Girls 11 and Up | work = [[The_New_York_Times|The New York Times]] | date = 30 June 2006 | accessdate = 2016-03-06 | archive-date = 2017-03-11 | archive-url = https://web.archive.org/web/20170311180315/http://www.nytimes.com/2006/06/30/health/30vaccine.html | dead-url = no }}
* [http://www.fda.gov/cber/products/gardasil.htm Product Approval Information]{{Wayback|url=http://www.fda.gov/cber/products/gardasil.htm |date=20090528164345 }} [[美國食品藥品監督管理局|美國食品藥品監督管理局]] (FDA)
* {{Cite news | last = Hellerstein | first = Myra | first2 = Amanda | last2 = Thieroff | url = http://www.indypendent.org/?p=750 | title = HPV and You: Girls learn about HPV from the commercials, not the classroom | work = {{link-en|The Indypendent|The Indypendent}} | date = 1 February 2007 | accessdate = 2016-03-06 | archive-date = 2014-12-24 | archive-url = https://web.archive.org/web/20141224081353/https://indypendent.org/?p=750 | dead-url = no }}
* {{Cite news | last = McNeil | first = Donald G., Jr. | authorlink = :en:Donald Gerard McNeil, Jr. | url = http://www.nytimes.com/2006/08/29/health/29hpv.html | title = How a Vaccine Search Ended in Triumph | work = [[The_New_York_Times|The New York Times]] | date = August 29, 2006 | accessdate = 2016-03-06 | archive-date = 2016-04-15 | archive-url = https://web.archive.org/web/20160415002425/http://www.nytimes.com/2006/08/29/health/29hpv.html | dead-url = no }}

{{Vaccines}}

[[Category:默克公司|Category:默克公司]]
[[Category:乳頭瘤病毒科|Category:乳頭瘤病毒科]]
[[Category:疫苗|Category:疫苗]]
[[Category:生命科学产业|Category:生命科学产业]]